Cash flow Orion Oyj

Equities

ORNBV

FI0009014377

Pharmaceuticals

Market Closed - Nasdaq Helsinki Other stock markets 12:00:00 2026-06-05 EDT			5-day change	1st Jan Change
69.85 ^EUR	+1.01%		-2.44%	+9.74%

06-01	Orion reports positive Phase 1 cancer data	FW
06-01	Orion's Solid Tumours Treatment Shows Early Efficacy, Favorable Safety Profile in Phase 1/2 Trial	MT

2b4004b7.x6IgAfJ4Bet47VT9sLENlIWstyzZ2OiqFwNydlib-oo.r5RQQ8scQdsyvgKH2Ndg2eDk7hSP79ncL0AcHwD-tPyVlQ17rStKoFWMZA

Published financial data: ORION OYJ

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	1.04B	1.34B	1.19B	1.54B	1.89B
Total Revenues	1.04B	1.34B	1.19B	1.54B	1.89B
Cost of Goods Sold, Total	448M	492M	532M	596M	676M
Gross Profit	594M	849M	658M	946M	1.21B
Selling General & Admin Expenses, Total	238M	279M	299M	336M	376M
R&D Expenses	118M	136M	127M	162M	210M
Other Operating Expenses	-2.8M	-4.5M	-5.5M	-6.5M	-5.1M
Other Operating Expenses, Total	353M	410M	420M	492M	581M
Operating Income	240M	439M	238M	454M	632M
Interest Expense, Total	-1M	-1.5M	-5.2M	-7.6M	-8.2M
Interest And Investment Income	100K	1M	2.9M	4.6M	4.6M
Net Interest Expenses	-900K	-500K	-2.3M	-3M	-3.6M
Income (Loss) On Equity Invest.	-	-	-	-	-
Currency Exchange Gains (Loss)	-300K	2.3M	-600K	-700K	300K
Other Non Operating Income (Expenses)	-200K	-400K	-600K	-700K	-500K
EBT, Excl. Unusual Items	239M	440M	234M	450M	628M
Gain (Loss) On Sale Of Investments	100K	300K	200K	300K	300K
Gain (Loss) On Sale Of Assets	3.9M	100K	7.7M	300K	-100K
Asset Writedown	-600K	-400K	-1M	-41M	-400K
Other Unusual Items	-	-	30.7M	3.4M	-
EBT, Incl. Unusual Items	242M	440M	272M	413M	628M
Income Tax Expense	48.5M	90.8M	55.1M	83.2M	128M
Earnings From Continuing Operations	194M	350M	217M	330M	500M
Earnings Of Discontinued Operations	-	-	-	-	-
Net Income to Company	194M	350M	217M	330M	500M
Net Income - (IS)	194M	350M	217M	330M	500M
Net Income to Common Incl Extra Items	194M	350M	217M	330M	500M
Net Income to Common Excl. Extra Items	194M	350M	217M	330M	500M
Per Share Items
Net EPS - Basic	1.38	2.49	1.54	2.35	3.56
Basic EPS - Continuing Operations	1.38	2.49	1.54	2.35	3.56
Basic Weighted Average Shares Outstanding	141M	141M	140M	140M	141M
Net EPS - Diluted	1.38	2.49	1.54	2.35	3.56
Diluted EPS - Continuing Operations	1.38	2.49	1.54	2.35	3.56
Diluted Weighted Average Shares Outstanding	141M	141M	140M	141M	141M
Normalized Basic EPS	1.06	1.96	1.04	2	2.79
Normalized Diluted EPS	1.06	1.96	1.04	2	2.79
Dividend Per Share	1.5	1.6	1.62	1.64	1.8
Payout Ratio	108.98	60.43	103.74	68.96	46.19
American Depositary Receipts Ratio (ADR)	0.5	0.5	0.5	0.5	0.5
Supplemental Items
EBITDA	282M	482M	284M	501M	682M
EBITA	247M	445M	245M	461M	640M
EBIT	240M	439M	238M	454M	632M
EBITDAR	284M	485M	288M	505M	685M
Effective Tax Rate - (Ratio)	20.02	20.62	20.26	20.14	20.31
Total Current Taxes	49.3M	89.6M	62.4M	84M	123M
Total Deferred Taxes	-800K	1.1M	-7.3M	-700K	4.5M
Normalized Net Income	149M	275M	146M	281M	392M
Interest on Long-Term Debt	200K	200K	200K	300K	600K
Non-Cash Pension Expense	200K	-400K	-32.3M	-200K	-100K
Supplemental Operating Expense Items
Selling and Marketing Expenses	190M	210M	224M	255M	289M
General and Administrative Expenses	47.9M	68.8M	74.8M	81.7M	86.7M
Research And Development Expense From Footnotes	118M	136M	127M	180M	210M
Net Rental Expense, Total	2M	3.2M	3.5M	3.7M	3.4M
Imputed Operating Lease Interest Expense	147K	238K	703K	853K	705K
Imputed Operating Lease Depreciation	1.85M	2.96M	2.8M	2.85M	2.69M
Stock-Based Comp., Other (Total)	7.6M	16M	12.2M	18.5M	21.5M
Total Stock-Based Compensation	7.6M	16M	12.2M	18.5M	21.5M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	217M	333M	107M	206M	161M
Short Term Investments	-	-	-	-	-
Total Cash And Short Term Investments	217M	333M	107M	206M	161M
Accounts Receivable, Total	175M	206M	297M	357M	694M
Other Receivables	12.7M	16M	8.7M	19.9M	17.5M
Notes Receivable	-	-	-	100K	300K
Total Receivables	188M	222M	306M	377M	712M
Inventory	265M	316M	362M	419M	456M
Prepaid Expenses	20.8M	8.1M	8M	12.9M	12.3M
Other Current Assets, Total	100K	700K	42.9M	2.2M	3.1M
Total Current Assets	690M	879M	825M	1.02B	1.34B
Gross Property Plant And Equipment	839M	870M	930M	990M	1.05B
Accumulated Depreciation	-538M	-558M	-593M	-621M	-650M
Net Property Plant And Equipment	301M	312M	337M	370M	401M
Long-term Investments	300K	300K	300K	300K	300K
Goodwill	13.5M	87.2M	87.2M	87.2M	87.2M
Other Intangibles, Total	55.5M	104M	113M	87.9M	100M
Loans Receivable Long-Term	200K	200K	700K	600K	2.3M
Deferred Tax Assets Long-Term	6.6M	3.1M	4.3M	8.3M	5.1M
Other Long-Term Assets, Total	46.5M	118M	71.3M	58.9M	69.5M
Total Assets	1.11B	1.5B	1.44B	1.63B	2.01B
Liabilities
Accounts Payable, Total	89.6M	114M	102M	87.1M	124M
Accrued Expenses, Total	73.8M	80.7M	70.8M	103M	135M
Short-term Borrowings	-	-	-	-	-
Current Portion of Long-Term Debt	-	13.8M	25.6M	25.6M	185M
Current Portion of Leases	3.8M	3.4M	3.4M	4.4M	5.2M
Current Income Taxes Payable	6.8M	1.4M	13.3M	9.5M	52M
Unearned Revenue Current, Total	13.1M	14.6M	15.7M	17.2M	18.4M
Other Current Liabilities	22.1M	47.1M	33.7M	26.6M	41.4M
Total Current Liabilities	209M	275M	265M	273M	560M
Long-Term Debt	100M	192M	166M	291M	106M
Long-Term Leases	4.7M	4.7M	4.7M	6.5M	9.4M
Unearned Revenue Non Current	12M	68.7M	66.8M	4.1M	2.3M
Pension & Other Post Retirement Benefits	4.9M	3M	4.1M	2.8M	2.6M
Deferred Tax Liability Non Current	34M	42.2M	31.8M	35.8M	37.4M
Other Non Current Liabilities	1.3M	9.4M	10M	10.8M	7.4M
Total Liabilities	366M	596M	548M	624M	725M
Common Stock, Total	92.2M	92.2M	92.2M	92.2M	92.2M
Retained Earnings	681M	823M	813M	922M	1.19B
Treasury Stock	-18.2M	-34.8M	-28M	-24.8M	-19.1M
Comprehensive Income and Other	-6.9M	27.8M	12.6M	15.5M	17.3M
Total Common Equity	748M	908M	890M	1B	1.28B
Total Equity	748M	908M	890M	1B	1.28B
Total Liabilities And Equity	1.11B	1.5B	1.44B	1.63B	2.01B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	141M	140M	140M	141M	141M
ECS Total Common Shares Outstanding	141M	140M	140M	141M	141M
Book Value / Share	5.32	6.48	6.34	7.15	9.13
Tangible Book Value	679M	717M	690M	830M	1.1B
Tangible Book Value Per Share	4.83	5.11	4.92	5.91	7.8
Total Debt	108M	214M	200M	327M	305M
Net Debt	-108M	-119M	93.3M	122M	144M
Debt Equivalent of Unfunded Proj. Benefit Obligation	-10.1M	-52.9M	-3.2M	-7.8M	-10.2M
Debt Equivalent Oper. Leases	16M	25.6M	28M	29.6M	27.2M
Equity Method Investments, Total	100K	100K	100K	100K	100K
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	62.6M	86.4M	94.1M	118M	157M
Inventories - Work In Process, Total	50.9M	69.9M	87.5M	95.6M	117M
Inventories - Finished Goods, Total	152M	159M	181M	205M	182M
Land - (BS)	5.6M	6.6M	6.6M	6.6M	6.6M
Buildings, Total	395M	415M	450M	472M	494M
Machinery, Total	415M	423M	450M	486M	518M
Full Time Employees	3.36K	3.53K	3.63K	3.88K	4.03K
Assets under Capital Lease - Gross	-	-	-	-	-
Assets under Capital Lease - Accumulated Depreciation	-	-	-	-	-
Accumulated Allowance for Doubtful Accounts (Supple)	-	-	200K	300K	200K

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	194M	350M	217M	330M	500M
Depreciation & Amortization - CF	38.3M	41M	43.6M	45.3M	48.6M
Amortization of Goodwill and Intangible Assets - (CF)	6.9M	6.5M	6.9M	6.1M	7.7M
Depreciation & Amortization, Total	45.2M	47.5M	50.5M	51.4M	56.3M
(Gain) Loss From Sale Of Asset	-3.9M	-100K	-7.7M	-300K	100K
Asset Writedown & Restructuring Costs	600K	-	1M	41.4M	400K
Net Cash From Discontinued Operations	-	-	-	-	-
Other Operating Activities, Total	16.3M	62.5M	3.2M	-57.7M	57.2M
Change In Accounts Receivable	-21.7M	11M	-89M	-35.8M	-336M
Change In Inventories	-6.9M	-4.1M	-47.9M	-56.4M	-38M
Change In Accounts Payable	-7.7M	-31.9M	-7.9M	20.9M	77M
Cash from Operations	216M	434M	119M	293M	317M
Capital Expenditure	-47M	-56.5M	-65.6M	-62.3M	-73.4M
Sale of Property, Plant, and Equipment	4.7M	900K	8.5M	1.7M	3M
Cash Acquisitions	-	-82M	-100K	-	-4M
Divestitures	-	-	-	-	-
Sale (Purchase) of Intangible assets	-38M	-16.6M	-51.2M	-24.6M	-24.2M
Other Investing Activities, Total	100K	-100K	-	-	-
Cash from Investing	-80.2M	-154M	-108M	-85.2M	-98.6M
Short Term Debt Issued, Total	2.9M	-	-	-	-
Long-Term Debt Issued, Total	-	101M	-	150M	-
Total Debt Issued	2.9M	101M	-	150M	-
Short Term Debt Repaid, Total	-6.5M	-	-	-	-
Long-Term Debt Repaid, Total	-	-31.4M	-18.4M	-30.9M	-32.6M
Total Debt Repaid	-6.5M	-31.4M	-18.4M	-30.9M	-32.6M
Repurchase of Common Stock	-	-17.9M	-	-	-
Common Dividends Paid	-211M	-211M	-225M	-228M	-231M
Common & Preferred Stock Dividends Paid	-211M	-211M	-225M	-228M	-231M
Special Dividend Paid	-	-	-	-	-
Other Financing Activities, Total	-	-100K	100K	-400K	100K
Cash from Financing	-215M	-160M	-243M	-109M	-264M
Foreign Exchange Rate Adjustments	1.6M	-4.4M	6.6M	-600K	700K
Miscellaneous Cash Flow Adjustments	-	-	-	-	-
Net Change in Cash	-77.7M	116M	-226M	98.8M	-44.7M
Supplemental Items
Cash Interest Paid	2.1M	5M	7.8M	9.2M	12M
Cash Income Tax Paid (Refund)	39.6M	95.6M	41.2M	87M	80.4M
Levered Free Cash Flow	87.46M	244M	-104M	178M	124M
Unlevered Free Cash Flow	88.09M	245M	-100M	182M	129M
Change In Net Working Capital	29.9M	19.7M	195M	84.6M	246M
Net Debt Issued / Repaid	-3.6M	69.4M	-18.4M	119M	-32.6M

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	13.47	20.96	10.1	18.52	21.7
Return on Total Capital	17.71	27.73	13.44	23.45	27.03
Return On Equity %	26.2	42.21	24.11	34.82	43.7
Return on Common Equity	26.2	42.21	24.11	34.82	43.7
Margin Analysis
Gross Profit Margin %	57.01	63.32	55.29	61.36	64.2
SG&A Margin	22.89	20.79	25.1	21.8	19.89
EBITDA Margin %	27.08	35.95	23.89	32.49	36.08
EBITA Margin %	23.75	33.22	20.57	29.86	33.84
EBIT Margin %	23.08	32.74	19.99	29.47	33.44
Income From Continuing Operations Margin %	18.62	26.07	18.22	21.39	26.48
Net Income Margin %	18.62	26.07	18.22	21.39	26.48
Net Avail. For Common Margin %	18.62	26.07	18.22	21.39	26.48
Normalized Net Income Margin	14.34	20.53	12.31	18.24	20.77
Levered Free Cash Flow Margin	8.4	18.21	-8.71	11.52	6.57
Unlevered Free Cash Flow Margin	8.46	18.28	-8.44	11.83	6.84
Asset Turnover
Asset Turnover	0.93	1.02	0.81	1.01	1.04
Fixed Assets Turnover	3.48	4.37	3.67	4.37	4.91
Receivables Turnover (Average Receivables)	6.27	6.85	4.73	4.72	3.6
Inventory Turnover (Average Inventory)	1.71	1.69	1.57	1.53	1.55
Short Term Liquidity
Current Ratio	3.3	3.19	3.12	3.72	2.4
Quick Ratio	1.93	2.01	1.56	2.13	1.56
Operating Cash Flow to Current Liabilities	1.03	1.58	0.45	1.07	0.57
Days Sales Outstanding (Average Receivables)	58.24	53.3	77.1	77.57	101.51
Days Outstanding Inventory (Average Inventory)	213.41	215.57	232.56	239.74	236.02
Average Days Payable Outstanding	70.78	68.68	68.36	53.13	53.81
Cash Conversion Cycle (Average Days)	200.88	200.19	241.3	264.19	283.72
Long Term Solvency
Total Debt/Equity	14.51	23.57	22.47	32.56	23.78
Total Debt / Total Capital	12.67	19.07	18.35	24.56	19.21
LT Debt/Equity	14	21.67	19.21	29.57	8.98
Long-Term Debt / Total Capital	12.23	17.54	15.69	22.31	7.25
Total Liabilities / Total Assets	32.86	39.6	38.13	38.31	36.09
EBIT / Interest Expense	240.3	292.6	45.73	59.8	77.05
EBITDA / Interest Expense	285.5	324.27	55.44	66.57	83.91
(EBITDA - Capex) / Interest Expense	238.5	286.6	42.83	58.37	74.96
Total Debt / EBITDA	0.38	0.44	0.69	0.65	0.44
Net Debt / EBITDA	-0.38	-0.24	0.32	0.24	0.21
Total Debt / (EBITDA - Capex)	0.45	0.5	0.9	0.74	0.5
Net Debt / (EBITDA - Capex)	-0.45	-0.28	0.42	0.27	0.24
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-3.44	28.78	-11.26	29.65	22.5
Gross Profit, 1 Yr. Growth %	-7.8	43.03	-22.76	43.87	28.17
EBITDA, 1 Yr. Growth %	-14.96	70.98	-41.03	76.98	35.92
EBITA, 1 Yr. Growth %	-17.05	80.18	-45.05	89	38.72
EBIT, 1 Yr. Growth %	-14.09	82.65	-45.81	91.93	38.89
Earnings From Cont. Operations, 1 Yr. Growth %	-11.87	80.34	-37.97	52.17	51.65
Net Income, 1 Yr. Growth %	-11.87	80.34	-37.97	52.17	51.65
Normalized Net Income, 1 Yr. Growth %	-14.43	84.3	-46.79	92.93	39.4
Diluted EPS Before Extra, 1 Yr. Growth %	-11.61	80.4	-38.09	52.5	51.46
Accounts Receivable, 1 Yr. Growth %	11.05	10.71	44.22	20.36	94.32
Inventory, 1 Yr. Growth %	2.75	19	14.77	15.57	9.01
Net Property, Plant and Equip., 1 Yr. Growth %	1.55	3.69	7.82	9.77	8.47
Total Assets, 1 Yr. Growth %	-0.14	34.97	-4.32	13.24	23.37
Tangible Book Value, 1 Yr. Growth %	-1.37	5.63	-3.78	20.28	32.18
Common Equity, 1 Yr. Growth %	2.27	21.42	-1.98	12.91	27.81
Cash From Operations, 1 Yr. Growth %	-27.88	101.39	-72.61	146.55	7.98
Capital Expenditures, 1 Yr. Growth %	38.24	20.21	16.11	-5.03	17.82
Levered Free Cash Flow, 1 Yr. Growth %	-60.96	179.06	-142.47	-270.47	-30.24
Unlevered Free Cash Flow, 1 Yr. Growth %	-60.78	178.15	-140.98	-280.66	-29.25
Dividend Per Share, 1 Yr. Growth %	0	6.67	1.25	1.23	9.76
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-0.48	11.51	6.9	7.26	26.02
Gross Profit, 2 Yr. CAGR %	-3.2	14.84	5.28	5.42	35.79
EBITDA, 2 Yr. CAGR %	-4.13	20.58	0.41	1.98	55.16
EBITA, 2 Yr. CAGR %	-4.96	22.26	-0.51	1.7	61.99
EBIT, 2 Yr. CAGR %	-2.72	25.27	-0.52	1.77	63.34
Earnings From Cont. Operations, 2 Yr. CAGR %	-1.66	26.07	5.77	-2.84	51.91
Net Income, 2 Yr. CAGR %	-1.66	26.07	5.77	-2.84	51.91
Normalized Net Income, 2 Yr. CAGR %	-2.38	25.58	-0.97	1.11	64.07
Diluted EPS Before Extra, 2 Yr. CAGR %	-1.65	26.28	5.68	-2.84	51.98
Accounts Receivable, 2 Yr. CAGR %	-5.68	14.32	26.39	31.73	52.93
Inventory, 2 Yr. CAGR %	7.31	10.58	16.87	15.17	12.24
Net Property, Plant and Equip., 2 Yr. CAGR %	-0.15	2.61	5.73	8.79	9.12
Total Assets, 2 Yr. CAGR %	3.71	16.09	13.64	4.09	18.2
Tangible Book Value, 2 Yr. CAGR %	-3.45	2.07	0.81	7.58	26.09
Common Equity, 2 Yr. CAGR %	-2.04	11.43	9.09	5.2	20.13
Cash From Operations, 2 Yr. CAGR %	-10.75	20.51	-25.72	-17.82	63.16
Capital Expenditures, 2 Yr. CAGR %	27.97	28.91	18.14	5.01	5.78
Levered Free Cash Flow, 2 Yr. CAGR %	-33.99	4.37	8.85	-14.66	9.13
Unlevered Free Cash Flow, 2 Yr. CAGR %	-33.99	4.44	6.75	-13.69	13.13
Dividend Per Share, 2 Yr. CAGR %	0	3.28	3.92	1.24	5.41
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	2.12	8.45	3.34	14	12.12
Gross Profit, 3 Yr. CAGR %	0.22	10.25	0.72	16.83	12.51
EBITDA, 3 Yr. CAGR %	-1.37	16.26	-5	21.14	12.26
EBITA, 3 Yr. CAGR %	-2.01	17.62	-6.36	23.05	12.82
EBIT, 3 Yr. CAGR %	-1.72	20.01	-5.27	23.67	12.92
Earnings From Cont. Operations, 3 Yr. CAGR %	-0.61	20.37	-0.47	19.4	12.7
Net Income, 3 Yr. CAGR %	-16.28	20.37	-0.47	19.4	12.7
Normalized Net Income, 3 Yr. CAGR %	-1.24	20.65	-5.68	23.51	12.57
Diluted EPS Before Extra, 3 Yr. CAGR %	-0.5	20.39	-0.43	19.42	12.66
Accounts Receivable, 3 Yr. CAGR %	-2.54	1.54	23.54	24.33	49.95
Inventory, 3 Yr. CAGR %	6.09	11.07	11.96	16.43	13.08
Net Property, Plant and Equip., 3 Yr. CAGR %	4.93	1.11	4.32	7.06	8.68
Total Assets, 3 Yr. CAGR %	-0.96	13.23	8.85	13.51	10.16
Tangible Book Value, 3 Yr. CAGR %	-1.45	-0.52	0.08	6.92	15.22
Common Equity, 3 Yr. CAGR %	-1.1	5.23	6.77	10.35	12.25
Cash From Operations, 3 Yr. CAGR %	-2.24	17.06	-26.45	10.8	-9.99
Capital Expenditures, 3 Yr. CAGR %	7.25	25.33	24.49	9.85	9.11
Levered Free Cash Flow, 3 Yr. CAGR %	-12.68	6.73	-22.67	26.66	-20.17
Unlevered Free Cash Flow, 3 Yr. CAGR %	-13.09	6.61	-23.55	27.47	-19.19
Dividend Per Share, 3 Yr. CAGR %	0	2.17	2.6	3.02	4
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-0.61	5.34	4.01	7.97	11.88
Gross Profit, 5 Yr. CAGR %	-1.86	6.62	2.21	8.36	13.51
EBITDA, 5 Yr. CAGR %	-3.28	8.1	-0.66	10.32	15.51
EBITA, 5 Yr. CAGR %	-3.96	8.61	-1.41	10.97	16.5
EBIT, 5 Yr. CAGR %	-3.88	9	-1.24	12.35	17.7
Earnings From Cont. Operations, 5 Yr. CAGR %	-4.89	9.8	1.89	10.48	17.87
Net Income, 5 Yr. CAGR %	-4.89	9.11	-8.08	10.48	17.87
Normalized Net Income, 5 Yr. CAGR %	-3.72	9.53	-1.13	12.42	17.6
Diluted EPS Before Extra, 5 Yr. CAGR %	-4.87	9.81	1.92	10.5	17.92
Accounts Receivable, 5 Yr. CAGR %	-2.67	0.66	9.47	12.69	34.54
Inventory, 5 Yr. CAGR %	3.11	6.96	10.28	12.69	12.07
Net Property, Plant and Equip., 5 Yr. CAGR %	3.12	3.58	5.25	4.12	6.21
Total Assets, 5 Yr. CAGR %	0.94	7.33	4.64	9.48	12.49
Tangible Book Value, 5 Yr. CAGR %	2.93	2.72	-0.55	2.65	9.77
Common Equity, 5 Yr. CAGR %	3.12	5.97	2.86	5.22	11.93
Cash From Operations, 5 Yr. CAGR %	-2.82	13.72	-12.42	1.62	1.16
Capital Expenditures, 5 Yr. CAGR %	2.67	-3.38	11.48	16.77	16.64
Levered Free Cash Flow, 5 Yr. CAGR %	-10.84	20.16	-4.63	-2.41	-11.14
Unlevered Free Cash Flow, 5 Yr. CAGR %	-11.04	19.57	-5.64	-2.03	-10.46
Dividend Per Share, 5 Yr. CAGR %	2.13	1.99	1.55	1.8	3.71